The definitive reference for researchers studying Epitalon — the synthetic tetrapeptide analogue of the pineal gland's epithalamin. Covers hTERT/telomerase activation, telomere biology, published longevity data, and research applications.
Epitalon is a synthetic tetrapeptide consisting of four amino acids in sequence: Ala-Glu-Asp-Gly (alanine-glutamic acid-aspartic acid-glycine). It was developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic analogue of epithalamin — a polypeptide fraction isolated from the bovine pineal gland.
The pineal gland produces melatonin and a variety of regulatory peptides that influence neuroendocrine function, circadian rhythm, and aging. Epithalamin — and by extension its synthetic analogue Epitalon — was identified as a pineal-derived bioregulator with effects on cellular aging, telomere maintenance, and lifespan in preclinical models. The Khavinson group published extensively on epithalamin and Epitalon across the 1980s–2010s, with peer-reviewed data in journals including Neuroendocrinology Letters, Bulletin of Experimental Biology and Medicine, and European Journal of Gerontology.
Epitalon's simple 4-amino acid sequence makes it one of the smallest bioactive peptides in longevity research — a feature that contributes to its metabolic stability relative to longer peptide chains and its ability to penetrate cell membranes to access nuclear transcription machinery.
Research Use Only: Corevanta's Epitalon is sold exclusively for laboratory and scientific research. It is not an approved drug, not a dietary supplement, and is not intended for human consumption or therapeutic use.
Epitalon's primary studied mechanism is the upregulation of hTERT — human telomerase reverse transcriptase — the catalytic enzyme subunit of telomerase. Telomerase is the ribonucleoprotein complex responsible for maintaining and extending telomeres: the repetitive DNA sequences (TTAGGG repeats) that cap and protect chromosome ends.
In most somatic (non-stem) cells, telomerase expression is epigenetically silenced. With each cell division, telomeres shorten because the DNA replication machinery cannot fully replicate the chromosome ends. When telomeres reach a critically short length, cells enter replicative senescence (the Hayflick limit) or undergo apoptosis. This telomere shortening is one of the most studied molecular mechanisms of biological aging.
Epitalon appears to derepress hTERT expression in somatic cells — partially re-activating the telomerase machinery that is normally silenced after embryonic development. Khavinson et al. (2003, Neuro Endocrinol Lett) showed hTERT mRNA upregulation in human fetal fibroblasts treated with Epitalon. This remains the most-cited mechanistic evidence for its telomerase-activating effect.
A secondary mechanism involves pinealocyte stimulation. Epitalon activates cells of the pineal gland to increase melatonin synthesis — connecting its longevity research profile to circadian biology. Melatonin itself has antioxidant and mitochondrial protective effects, and age-related melatonin decline is a documented feature of biological aging. Epitalon's pineal stimulation may thus exert indirect aging-relevant effects through multiple melatonin-dependent pathways.
| Mechanism | Effect | Research Relevance |
|---|---|---|
| hTERT upregulation | Telomerase re-activation in somatic cells | Telomere length maintenance research |
| Pinealocyte activation | Increased melatonin synthesis | Circadian biology, antioxidant mechanisms |
| Antioxidant effects | Reduced 8-OHdG, oxidative stress markers | Cellular aging, DNA damage research |
| Immune modulation | T-cell function preservation with age | Immune senescence models |
| Retinal cytoprotection | Photoreceptor preservation in retinal aging | Retinitis pigmentosa, AMD models |
Understanding why Epitalon is relevant to telomere research requires a brief primer on the telomere shortening mechanism and the role of telomerase in counteracting it.
Telomeres consist of thousands of TTAGGG hexanucleotide repeats at each chromosome end, bound by a complex of proteins (shelterin) that prevent the DNA from being recognized as a double-strand break. With each cell division, the "end replication problem" results in loss of 50–200 base pairs from each telomere end. In cells where this process is not counteracted — most differentiated somatic cells — telomeres shorten progressively until a critically short length triggers senescence, cell death, or genomic instability.
In stem cells, germ cells, and most cancers, telomerase is active — continuously adding TTAGGG repeats to restore telomere length. Epitalon's studied mechanism sits in this space: partial re-activation of hTERT in cells where it is normally silenced. The research question is whether this re-activation is sufficient, safe, and specific enough to provide meaningful telomere length maintenance without triggering oncogenic pathways.
Published rodent lifespan data from the Khavinson group reported 13–33% increases in median lifespan across several experimental protocols, alongside reduced markers of cellular senescence, maintained immune function, and preserved hormonal profiles. These results, while in animal models, represent some of the most specific published data linking a peptide compound to longevity outcomes through a telomere-based mechanism.
Corevanta's Epitalon is manufactured to ≥99% purity (HPLC), with LC-MS mass identity confirmation and a third-party COA included with every order. Available in 10mg and 50mg lyophilized vials.